Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial

Published:2018-08-03 Issue:1 Volume:104 Page:113-119
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Lambert Juliette,Pautas Cécile,Terré Christine,Raffoux Emmanuel,Turlure Pascal,Caillot Denis,Legrand Ollivier,Thomas Xavier,Gardin Claude,Gogat-Marchant Karïn,Rubin Stephen D.,Benner Rebecca J.,Bousset Pierre,Preudhomme Claude,Chevret Sylvie,Dombret Herve,Castaigne Sylvie

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 252 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Acute Myeloid Leukemia in the Community Setting;The Oncologist;2024-08-19

2. Dermatologic toxicities of antibody-drug conjugates;Journal of the American Academy of Dermatology;2024-08

3. ANZTCT practice statement: sinusoidal obstruction syndrome/veno‐occlusive disease diagnosis and management;Internal Medicine Journal;2024-07-30

4. Looking ahead to CD3, T-cell engager bispecific antibodies for hematological malignancies;Expert Opinion on Biological Therapy;2024-07-29

5. Real‐world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia;eJHaem;2024-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP